Stay updated on NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial

Sign up to get notified when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Status updated to Active, not recruiting, with enrollment reported as 107 and primary completion set for 2026-12. The principal investigator's contact information was removed from the page.
    Difference
    1%
    Check dated 2026-05-22T14:06:36.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page revision has been updated to v3.5.4, indicating a backend or rendering system update. No changes to the displayed study information are introduced.
    Difference
    0.1%
    Check dated 2026-05-15T11:43:18.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a non-content site release.
    Difference
    0.1%
    Check dated 2026-04-24T06:37:44.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:47:33.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Site version updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T06:14:05.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:39:58.000Z thumbnail image

Stay in the know with updates to NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.